CIK 0000908259
- Non-accelerated filer
- Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133679168
- Phone
- +1 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- Open-market buys, last 90 days
- $23,537
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,537. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2005-05-19 | SHIEBLER WILLIAM N Director | Purchase | +15,000 | $4.48 | $67K | 61,000 |
| 2005-05-19 | LAFFER ARTHUR B Director | Purchase | +25,000 | $4.37 | $109K | 120,140 |
| 2004-08-23 | CITRON JOEL TOMAS Director | Purchase | +4,400 | $4.69 | $21K | 210,377 |
| 2004-08-23 | CITRON JOEL TOMAS Director | Purchase | +600 | $4.65 | $3K | 210,977 |
| 2004-08-23 | SHIEBLER WILLIAM N Director | Purchase | +6,000 | $4.67 | $28K | 46,000 |
| 2004-08-18 | LAFFER ARTHUR B Director | Purchase | +1,509 | $4.37 | $7K | 91,649 |
| 2004-08-18 | LAFFER ARTHUR B Director | Purchase | +1,000 | $4.38 | $4K | 92,649 |
| 2004-08-18 | LAFFER ARTHUR B Director | Purchase | +2,491 | $4.40 | $11K | 95,140 |
| 2004-07-28 | Zecher Richard Director | Grant or award · Options to purchase Common Stock | +40,000 | 40,000 | ||
| 2004-07-28 | CHAPLIN DAVID Chief Scientific Officer | Grant or award · Options to purchase Common Stock | +50,000 | 50,000 | ||
| 2004-07-28 | CITRON JOEL TOMAS Director | Grant or award · Options to purchase Common Stock | +25,000 | 25,000 | ||
| 2004-07-28 | DRISCOLL FREDERICK W President and CEO | Grant or award · Options to purchase Common Stock | +50,000 | 50,000 | ||
| 2004-07-28 | MURPHY JAMES B Chief Financial Officer | Grant or award · Options to purchase Common Stock | +20,000 | 20,000 | ||
| 2004-07-28 | YOUNG SCOTT Chief Operating Officer | Grant or award · Options to purchase Common Stock | +30,000 | 30,000 | ||
| 2004-07-28 | LAFFER ARTHUR B Director | Grant or award · Options to purchase Common Stock | +10,000 | 10,000 | ||
| 2004-07-28 | SHIEBLER WILLIAM N Director | Grant or award · Options to purchase Common Stock | +10,000 | 10,000 | ||
| 2004-07-28 | SODERBERG PER OLOF Director | Grant or award · Options to purchase Common Stock | +10,000 | 10,000 | ||
| 2004-05-21 | CHAPLIN DAVID Chief Scientific Officer | Purchase | +200 | $7.47 | $1K | 200 |
| 2004-05-21 | CHAPLIN DAVID Chief Scientific Officer | Purchase | +1,500 | $7.46 | $11K | 1,700 |
| 2004-05-21 | CHAPLIN DAVID Chief Scientific Officer | Purchase | +200 | $7.45 | $1K | 1,900 |
Page 20 of 21 · 411 trades